Skip to Main Content

Author Details

Ahmet Hoke
Johns Hopkins School of Medicine
1994
193
55
PMIDPaper TitleJournal TitlePublished Year
36314214A Heterozygous Mutation in MFF Associated with a Mild Mitochondrial Phenotype.J Neuromuscul Dis2023
37860842Senescent Schwann cells induced by aging and chronic denervation impair axonal regeneration following peripheral nerve injury.EMBO Mol Med2023
37015772Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence.J Neurol Neurosurg Psychiatry2023
37078472Deletion of quinolinate phosphoribosyltransferase gene accelerates frailty phenotypes and neuromuscular decline with aging in a sex-specific pattern.Aging Cell2023
36468201In Memoriam: Daniel B. Drachman.Ann Neurol2023
36574260Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis.Ann Clin Transl Neurol2023
36658684Change of guard at ACTN.Ann Clin Transl Neurol2023
34794826Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair.Biomaterials2022
35570838Biomimicking Fiber Scaffold as an Effective In Vitro and In Vivo MicroRNA Screening Platform for Directing Tissue Regeneration.Adv Sci (Weinh)2022
35912598Grateful Giving in Medicine: A Personal Story.Narrat Inq Bioeth2022
34968623Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: Systematic review and evidence-based recommendations.Crit Rev Oncol Hematol2022
34931740Vitamin B6 levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy.J Peripher Nerv Syst2022
35137510SARM1 knockout does not rescue neuromuscular phenotypes in a Charcot-Marie-Tooth disease Type 1A mouse model.J Peripher Nerv Syst2022
35019936cADPR induced calcium influx mediates axonal degeneration caused by paclitaxel.J Cell Biol2022
34894974Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion.Expert Rev Neurother2022
33035659Use of electromyography to predict likelihood of recovery following C5 palsy after posterior cervical spine surgery.Spine J2021
33564774RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASES.medRxiv2021
33607079Defining the relative impact of muscle versus Schwann cell denervation on functional recovery after delayed nerve repair.Exp Neurol2021
34491913Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice.J Clin Invest2021
34768313Normal structure and pathological features in peripheral neuropathies.J Peripher Nerv Syst2021
34249891Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury.Front Bioeng Biotechnol2021
34128833GADD45A is a protective modifier of neurogenic skeletal muscle atrophy.JCI Insight2021
34291431Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral Neuropathy.Neurotherapeutics2021
34059824Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.Nat Med2021
34031437Ethoxyquin is neuroprotective and partially prevents somatic and autonomic neuropathy in db/db mouse model of type 2 diabetes.Sci Rep2021
33947785Large Mitochondrial DNA Deletions in HIV Sensory Neuropathy.Neurology2021
33359733New evidence for secondary axonal degeneration in demyelinating neuropathies.Neurosci Lett2021
31453649Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging.Glia2020
31812556Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations.Exp Neurol2020
31689415Targeting the programmed axon degeneration pathway as a potential therapeutic for Charcot-Marie-Tooth disease.Brain Res2020
33055271Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria.Neurology2020
33025680Relation of exercise and pain in patients with idiopathic distal axonal polyneuropathies.J Peripher Nerv Syst2020
33318563Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation.Sci Rep2020
32814718Kynurenines link chronic inflammation to functional decline and physical frailty.JCI Insight2020
32152523Programmed axon degeneration: from mouse to mechanism to medicine.Nat Rev Neurosci2020
32533969Cellular and molecular features of neurogenic skeletal muscle atrophy.Exp Neurol2020
30611662Scaffold-Mediated Sustained, Non-viral Delivery of miR-219/miR-338 Promotes CNS Remyelination.Mol Ther2019
31638597Fracture repair requires TrkA signaling by skeletal sensory nerves.J Clin Invest2019
31325319Stimulated grip strength measurement: Validation of a novel method for functional assessment.Muscle Nerve2019
31208527Mitochondrial dysfunction in HIV-induced peripheral neuropathy.Int Rev Neurobiol2019
31551418Longitudinal RNA-Seq analysis of acute and chronic neurogenic skeletal muscle atrophy.Sci Data2019
31484833Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.JCI Insight2019
31511601The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.Sci Rep2019
31306565Oligodendrocyte precursors gain Schwann cell-like phenotype and remyelinate axons upon engraftment into peripheral nerves.J Tissue Eng Regen Med2019
30807875Macroporous nanofiber wraps promote axonal regeneration and functional recovery in nerve repair by limiting fibrosis.Acta Biomater2019
31065509Biomimicking Fiber Scaffold as an Effective In Vitro and In Vivo MicroRNA Screening Platform for Directing Tissue Regeneration.Adv Sci (Weinh)2019
30962586Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder.Nat Biomed Eng2019
30816300Growth Hormone Improves Nerve Regeneration, Muscle Re-innervation, and Functional Outcomes After Chronic Denervation Injury.Sci Rep2019
30715378The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.J Natl Cancer Inst2019
30630001Evaluation of select biocompatible markers for labelling peripheral nerves on 11.7 T MRI.J Neurosci Methods2019
  • 1 - 50 of 193

Recommended Authors

University of California San Diego
Career Start Year 2013
Number of shared co-authors 1
University of Arizona College of Medicine
Career Start Year 2013
Number of shared co-authors 0
Seoul National University
Career Start Year 2012
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2008
Number of shared co-authors 0
Washington University
Career Start Year 2008
Number of shared co-authors 0
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 2007
Number of shared co-authors 0
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Baylor Scott and White Health and Texas A&M University College of Medicine
Career Start Year 2003
Number of shared co-authors 0
Manitoba Multiple Sclerosis Research Center
Career Start Year 2002
Number of shared co-authors 2
Dresden International University
Career Start Year 2000
Number of shared co-authors 0
University of Manitoba
Career Start Year 2000
Number of shared co-authors 0
Spencer Center for Vision Research, Byers Eye Institute, Stanford University
Career Start Year 1998
Number of shared co-authors 3
Montreal Children's Hospital, McGill University
Career Start Year 1997
Number of shared co-authors 2
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1996
Number of shared co-authors 0
Gladstone Institute for Neurological Disease San Francisco
Career Start Year 1995
Number of shared co-authors 2
Novartis Gene Therapies
Career Start Year 1994
Number of shared co-authors 2
Brigham Women's Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 3
Duke University
Career Start Year 1992
Number of shared co-authors 1
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
University of California san francisco
Career Start Year 1990
Number of shared co-authors 2
National Center for Advancing Translational Sciences
Career Start Year 1990
Number of shared co-authors 0
UCL Queen Square Institute of Neurology
Career Start Year 1989
Number of shared co-authors 1
Gilbert Family Foundation
Career Start Year 1988
Number of shared co-authors 0
J. David Gladstone Institutes
Career Start Year 1988
Number of shared co-authors 4
University of California San Diego
Career Start Year 1987
Number of shared co-authors 2
National Institute of Neurological Disorders and Stroke
Career Start Year 1986
Number of shared co-authors 2
Sheffield Institute for Translational Neuroscience, University of Sheffield
Career Start Year 1983
Number of shared co-authors 3
Boston Children's Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1977
Number of shared co-authors 4
University of California San Diego
Career Start Year 1973
Number of shared co-authors 3

Collaborators

Institute of Stem Cells and Regenerative Medicine (inStem)
Co-authored papers 7
Johns Hopkins University School of Medicine
Co-authored papers 6
Johns Hopkins School of Medicine
Co-authored papers 5
NeuroMI (Milan Center for Neuroscience)
Co-authored papers 5
Johns Hopkins University School of Medicine
Co-authored papers 5
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 4
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
Co-authored papers 3
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 3
Co-authored papers 3
W.M. Keck Center for Collaborative Neuroscience, The State University of New Jersey
Co-authored papers 3
Phoebe R Berman Bioethics Institute
Co-authored papers 3
The Center for Law and the Biosciences, Stanford University
Co-authored papers 3
Harvard Medical School and McLean Hospital
Co-authored papers 3
New York University.
Co-authored papers 3
Johns Hopkins University School of Medicine Abarbanel Mental Health Centre
Co-authored papers 3
Johns Hopkins Berman Institute of Bioethics
Co-authored papers 3
Johns Hopkins Hospital
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
IRCCS Casa Sollievo della Sofferenza, University of Milano-Bicocca
Co-authored papers 3
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 3
Co-authored papers 3
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 3
Johns Hopkins University
Co-authored papers 3
Marcus Center for Cellular Cures, Duke University School of Medicine
Co-authored papers 3
New York Presbyterian Hospital, Columbia University Medical Center
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
National Institutes of Health, National Institute of Neurological Diseases and Stroke
Co-authored papers 3